STIM vs. PDEX, DRIO, ICAD, TTOO, PYPD, PROF, DCTH, TLSI, CVRX, and NPCE
Should you be buying Neuronetics stock or one of its competitors? The main competitors of Neuronetics include Pro-Dex (PDEX), DarioHealth (DRIO), iCAD (ICAD), T2 Biosystems (TTOO), PolyPid (PYPD), Profound Medical (PROF), Delcath Systems (DCTH), TriSalus Life Sciences (TLSI), CVRx (CVRX), and NeuroPace (NPCE). These companies are all part of the "surgical & medical instruments" industry.
Pro-Dex (NASDAQ:PDEX) and Neuronetics (NASDAQ:STIM) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, analyst recommendations, dividends, community ranking and media sentiment.
Neuronetics has a consensus price target of $8.00, indicating a potential upside of 257.14%. Given Pro-Dex's higher possible upside, analysts plainly believe Neuronetics is more favorable than Pro-Dex.
Pro-Dex received 22 more outperform votes than Neuronetics when rated by MarketBeat users. However, 68.48% of users gave Neuronetics an outperform vote while only 60.91% of users gave Pro-Dex an outperform vote.
15.3% of Pro-Dex shares are held by institutional investors. Comparatively, 53.6% of Neuronetics shares are held by institutional investors. 42.6% of Pro-Dex shares are held by insiders. Comparatively, 9.8% of Neuronetics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Pro-Dex has higher earnings, but lower revenue than Neuronetics. Neuronetics is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.
Pro-Dex has a beta of 0.41, suggesting that its share price is 59% less volatile than the S&P 500. Comparatively, Neuronetics has a beta of 2.32, suggesting that its share price is 132% more volatile than the S&P 500.
In the previous week, Neuronetics had 2 more articles in the media than Pro-Dex. MarketBeat recorded 4 mentions for Neuronetics and 2 mentions for Pro-Dex. Pro-Dex's average media sentiment score of 1.43 beat Neuronetics' score of 0.31 indicating that Neuronetics is being referred to more favorably in the news media.
Pro-Dex has a net margin of 4.13% compared to Pro-Dex's net margin of -37.61%. Neuronetics' return on equity of 6.50% beat Pro-Dex's return on equity.
Summary
Pro-Dex beats Neuronetics on 9 of the 17 factors compared between the two stocks.
Get Neuronetics News Delivered to You Automatically
Sign up to receive the latest news and ratings for STIM and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding STIM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Neuronetics Competitors List
Related Companies and Tools